McKesson Corporation

NYSE:MCK

Medical - Distribution

Healthcare
$1,084.43 -3.71%

-$28.96 today

Market cap
$125.21B
Beta
0.32
P/E (TTM)
19.3
EPS (TTM)
$39.00
Dividend yield
0.44%
52W Low $637.00High $999.00

Volume 0.67M

Average 1.03M

MCK Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

McKesson CorporationNYSE: MCK

Accounts Payables · Q1 FY2027 · quarter ended Jun 2026

Accounts payables grows, but more slowly than its trailing trend

Q1 FY2027 accounts payables of $3.77B rose 93.8% year over year, behind the +215.5% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at +4.5% a year.

Context

  • Accounts payables amounted to 1.1% of revenue in FY2026, up 1.1 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +93.8% toward the trailing-twelve-month pace of +215.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$3.77B+757.3% QoQ
Last fiscal yearMar 2026
$4.32B— YoY
LTMJun 2026
$6.14B+215.5% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+93.8%——
1 year———
3-year CAGR+4.5%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2026
4.32B USD
Year-over-year change
—
4-year CAGR
+11.4%

Accounts Payables vs competitors

How MCK compares with its peers on the latest reported figures

  • MCK's LTM Jun 2026 accounts payables of $6.14B is the largest of the 4 companies compared; the peer median is $3.97B.
  • Its year-over-year change of +215.5% is the 2nd highest of 4, against a peer median of -36.7%.
  • Accounts payables amounts to 1.5% of revenue for MCK, versus a peer median of 1.5%.
MCK Competitors Peer median
Accounts Payables for MCK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MCKMcKesson CorporationLTM Jun 2026$6.14B +215.5%+4.5%1.5%
CORCencora, Inc.LTM Jun 2026$4.39B +453.0%+3.6%1.3%
CAHCardinal Health, Inc.LTM Sep 2026$3.97B -36.7%+7.1%1.5%
ACHAccendra Health, Inc.LTM Mar 2026$142.42M -183.8%-22.0%5.2%
Peer median (excluding MCK) $3.97B-36.7%+3.6%1.5%

Competitors are the stored peer set for MCK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income1.29B3.72B3.16B3.48B4.76B
Depreciation & Amortization760M608M635M636M729M
Deferred Income Tax34M(20M)(603M)(110M)230M
Stock-Based Compensation161M162M000
Change in Working Capital82M384M(64M)1.16B162M
Accounts Receivables(1.84B)(1.08B)(2.95B)(3.94B)(2B)
Inventory(1.17B)(1.26B)(1.29B)(2.27B)(1.08B)
Accounts Payables2.8B3.79B004.32B
Other Working Capital292M(1.06B)4.18B7.36B(1.07B)
Other Non-Cash Items2.11B303M1.19B923M272M
Operating Cash Flow4.43B5.16B4.31B6.09B6.16B
Capital Expenditures(535M)(558M)(687M)(859M)(745M)
Acquisitions (Net)572M210M(225M)155M(2.59B)
Purchases of Investments(446M)0000
Sales of Investments446M866M000
Other Investing Activities(126M)(1.06B)(416M)(351M)(101M)
Investing Cash Flow(89M)(542M)(1.07B)(733M)(3.43B)
Debt Repayment(1.15B)(277M)56M(21M)783M
Common Stock Issued220M163M116M101M89M
Common Stock Repurchased(3.52B)(3.64B)(3.03B)(3.15B)(4.75B)
Dividends Paid(277M)(292M)(314M)(345M)(381M)
Other Financing Activities(1.38B)(324M)(175M)(554M)(372M)
Financing Cash Flow(6.32B)(4.37B)(3.34B)(3.97B)(4.63B)
Effect of Forex Changes(485M)495M6M(16M)(73M)
Net Change in Cash(2.46B)744M(94M)1.37B(1.98B)
Free Cash Flow3.9B4.6B3.63B5.23B5.41B

McKesson Corporation

NYSE:MCK

Intrinsic Alpha fair value

Locked

Current Price

$1,084.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.